Genomma Lab InternacionalB de CV (MEX:LABB) Operating Cash Flow per Share : MXN3.04 (TTM As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is Genomma Lab InternacionalB de CV Operating Cash Flow per Share?

Genomma Lab InternacionalB de CV's operating cash flow per share for the three months ended in Mar. 2025 was MXN-0.16. Genomma Lab InternacionalB de CV's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was MXN3.04.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Genomma Lab InternacionalB de CV was 59.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 28.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 22.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's Operating Cash Flow per Share or its related term are showing as below:

MEX:LABB' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -31 Med: 11.5 Max: 140.8
Current: 28.6

During the past 13 years, Genomma Lab InternacionalB de CV's highest 3-Year average Operating Cash Flow per Share Growth Rate was 140.80% per year. The lowest was -31.00% per year. And the median was 11.50% per year.

MEX:LABB's 3-Year OCF Growth Rate is ranked better than
72.02% of 772 companies
in the Drug Manufacturers industry
Industry Median: 8.6 vs MEX:LABB: 28.60

Genomma Lab InternacionalB de CV Operating Cash Flow per Share Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV Operating Cash Flow per Share Chart

Genomma Lab InternacionalB de CV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

1.70

1.46

2.07

2.35

3.10

Genomma Lab InternacionalB de CV Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.13	0.44	1.46	1.30	-0.16

Competitive Comparison of Genomma Lab InternacionalB de CV's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomma Lab InternacionalB de CV's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Genomma Lab InternacionalB de CV Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Genomma Lab InternacionalB de CV's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	3033.717	/	978.430
	=	3.10

Genomma Lab InternacionalB de CV's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-151.017	/	973.793
	=	-0.16

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN3.04

Genomma Lab InternacionalB de CV Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomma Lab InternacionalB de CV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (MEX:LABB) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

GNMLF:USA GEKA:Germany

Address

Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210

Website

https://www.genommalab.com

Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV Headlines

No Headlines